Lupus & antiphospholipid syndrome
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus
Methodological detailsDeveloped per the BSR Guidelines Protocol by a Guideline Working Group of healthcare professionals with paediatric and adult systemic lupus erythematosus (SLE) expertise and people with lived experience, Review of published guidelines, systematic literature review, expertise from UK specialist lupus centres and patient representatives
- Developed per the BSR Guidelines Protocol by a Guideline Working Group of healthcare professionals with paediatric and adult SLE expertise and people with lived experience
- Review of published guidelines, systematic literature review, expertise from UK specialist lupus centres and patient representatives
Scope
As issued by the authors
Life-course management of SLE in children, young people and adults: assessment, diagnosis, monitoring, general, non-pharmacological and pharmacological management, organ-specific treatment incl. LN and CLE, and delivery of care in the UK healthcare system; 102 recommendations with strength of recommendation and agreement scores
Original publication
The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus. Rheumatology (Oxford). Published 24 June 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →